Mayo Clinic Uncovers Genetic Cancer Risks in 550 Patients
Screening protocols can fail to spot those with mutations that may lead to cancer, highlighting a need for better genetic testing guidelines.
Read MorePosted by Andy Lundin | Jul 17, 2024 | Cancer, Molecular Diagnostics |
Screening protocols can fail to spot those with mutations that may lead to cancer, highlighting a need for better genetic testing guidelines.
Read MorePosted by Andy Lundin | Jul 1, 2024 | Prostate |
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read MorePosted by Andy Lundin | Jun 26, 2024 | Digital Pathology |
Proscia has had success in the pathology market, driven by successful AI-enabled workflows and reinforced via new research and study results.
Read MorePosted by Andy Lundin | Jun 20, 2024 | Cancer |
A new study reveals that AI can detect and diagnose cancer from tissue samples with 98.2% accuracy, allowing for earlier treatment.
Read MorePosted by Andy Lundin | Jun 19, 2024 | Cancer |
Alverno Labs has implemented Ibex’s AI-powered platform, enhancing cancer diagnosis for prostate, breast, and gastric biopsies.
Read More